Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Darrin L Baines Health
Economics Facility, Health Services Management Centre, University of
Birmingham, Park House, Birmingham B15 2RT
Correspondence to: D L
Baines Bainesdl{at}hsmc.bham.ac.uk
In April 1991 prescribing budgets were introduced
into English general practice as part of the fundholding and indicative prescribing schemes.1 The schemes were designed to control the growth in public expenditure on drugs and to reduce the variation in prescribing costs that existed between general practitioners in
different parts of the country. Initially, practice level prescribing budgets were set on a historical cost basis. This approach was criticised, however, for being inequitable and for possibly rewarding high cost, inefficient practices with more funds.2 In
response, a move to budgets set on a weighted capitation basis was
recommended as a means of promoting equity while ensuring that funding
levels reflected the needs of patients locally.
The identification of several limitations of the weighted capitation
formula that was used to help set prescribing budgets in England from
1993-4 onwards led to a debate about the desirability of using such an
approach. Majeed argued that variations in general practice prescribing
costs were too large to be explained in this way.3 He
suggested that the rigid, inflexible application of weighted capitation
formulas to help set practice level prescribing budgets should be
avoided. In a similar vein, Majeed and Head argued that weighted
capitation formulas were very crude tools for determining general
practice prescribing budgets and should be used only as a guide to
allocations.4 Greenhalgh concluded that such formulas
should not be used as substitutes for factors such as reflection or
negotiation during the budget setting process.5 Maxwell,
Howie, and Pryde reported that the formula used to help set practice
level budgets failed to take account of factors such as patients'
values, beliefs, and expectations.6 Finally, Smith argued
that the formula did not reflect all patient related variations in
costs, random variations in need, and differences in clinical practice.
In consequence, he argued, such formulas should be used with great
caution.7
Summary points
The existing weighted capitation formula used for setting
prescribing budgets in English general practice has known limitations
A new needs adjustment formula was designed to address many of these
limitations
As the new formula was developed using a similar procedure for
identifying patients' needs, it embodies some of the limitations of
its predecessor
In particular, the new formula may have institutionalised historical
prescribing patterns and may fail to measure patients' needs directly
The new formula should be subjected to piloting and a formal evaluation
before it is recommended for use nationally
Despite concerns about the use of weighted capitation formulas in the
setting of practice level prescribing budgets, the "new NHS" white
paper announced that from April 1999 onwards all practices in England
would be allocated a budget for prescribing under the auspices of the
newly established primary care groups.8 To help improve
the basis on which such budgets are set, the NHS Executive commissioned
researchers from York University and the Prescribing Support Unit to
identify which factors other than patient age, sex and temporary
resident status were associated with variations in costs. In June 1999 the NHS Executive published the final formula produced by the research
team with the recommendation that it be used by primary care groups to
help guide practice level prescribing allocations. In response, we
outline some of the main deficiencies of the formula and conclude that
the approach used during its construction may have institutionalised
historical prescribing patterns and failed to measure variations in
patients' needs for prescribed drugs.
| |
Development of a weighted capitation formula for prescribing |
|---|
|
|
|---|
As practice level prescribing budgets had not been set before April 1991, the NHS lacked a robust weighted capitation formula for their allocation. At the time, the only available prescribing cost denominator was the "prescribing unit," which weighted patients aged under 65 years as one and those aged 65 and over as three. The prescribing unit was used by many health authorities to help compare costs between practices within their areas. Evidence suggested, however, that the measure failed to account for differences in age and sex related variations in prescribing spending.9 In response, the ASTRO-PU (age, sex, and temporary resident originated prescribing unit) was developed; this contained weights believed to reflect the distribution of prescribing costs, in relation to age and sex, in English general practice.10 Although the ASTRO-PU was superior to the prescribing unit, the architects of the new measure stated that many factors other than the age and sex structure of a practice population influenced prescribing and that its weightings accounted for only about 25% of the variations in costs between practices.10
Not only was the ASTRO-PU unable to explain 75% of the variation in prescribing costs per practice nationally, but its explanatory power was also challenged by changes in prescribing patterns over time. As prescribing patterns had changed substantially since the measure's construction during the early 1990s, the ASTRO-PU's weights were recalculated using data from November 1995 to October 1996. The new measure, the ASTRO(97)-PU, gave larger weights to patients under the age of 65 and reduced some of the weightings for older patients. Given the greater accuracy of these weightings, the architects of the ASTRO(97)-PU suggested that these new weightings should be used for budget setting.11
Although the ASTRO(97)-PU was designed to be more accurate than
the ASTRO-PU, it embodied several weaknesses similar to those of its
predecessor. In particular, the new measure used only one set of
weightings for all practices nationally and did not measure need in
terms of patients "capacity to benefit" from prescribed drugs
that
is, their ability to improve their health status through the
consumption of pharmaceutical products.12 In consequence, the ASTRO(97)-PU was unable to guarantee that (a)
practices would be funded for all legitimate variations in costs,
(b) its national weights were applicable at a local
level, and (c) prescribing allocations would accurately
reflect patients' needs.
|
| |
New needs adjustment formula for prescribing |
|---|
|
|
|---|
In response to the publication of the "new NHS" white paper, the NHS Executive commissioned researchers from the University of York and the Prescribing Support Unit to develop a needs based formula for adjusting prescribing allocations made on the basis of the ASTRO(97)-PU.13 The logic behind this move was that such a formula would be able to improve the basis on which budgets are set by accounting for the factors related to need not included in the ASTRO(97)-PU. The researchers used multiple regression modelling to explain practice level variations in prescribing expenditures. Based on data for 8506 English practices for 1997-8 their model explained 41% of the variation in costs, above that accounted for by the ASTRO(97)-PU with four "need" and five "supply" variables (plus a variable designed to correct for differences in list inflation between practices). Although the scheme was abolished in March 1999, the model also included a variable designed to account for the assumed endogeneity of fundholding status among the practices sampled.
The need variables included in the needs adjustment formula were based
on responses to questions asked by the 1991 census. In this context,
the use of census variables presents two main problems. Firstly, such
variables are prone to random and systematic errors and, in some areas,
may not accurately reflect the true values of the variables that they
are trying to measure.
14 15
Secondly, they do not measure
need in terms of patients' capacity to benefit from available
interventions
for example, the "permanent sickness" variable was
designed to measure the proportion of the population unable to work
owing to long term illness or disability and was not designed to
measure people's ability to benefit from prescribed drugs. Despite
these limitations, the Advisory Committee on Resource Allocation for
the NHS in England recommended a revised version of the needs
adjustment formula for use by primary care groups, which only included
the variables for permanent sickness, no carer, students, and
babies.16 The supply variables, on the other hand, were
dropped from the recommended formula, as they were not deemed to
represent need related variations in costs.
| |
Discussion |
|---|
|
|
|---|
The architects of the ASTRO(97)-PU and of the needs
adjustment formula adopted a "positive" approach to explain
practice level variations in prescribing costs
that is, they based
their research on prescribing patterns that were observed during the
years in which they sampled their data. The researchers could have
adopted a "normative" approach, whereby they would have specified
the factors that should determine variations in costs and the influence they should have during the budget setting process.17 A
normative statement could be that "extra funding should be provided
for patients exempt from the prescription charge" or that "15 times as much should be spent on men aged over 75 years."
By using a positive approach, the researchers may have fallen foul of
the "naturalistic fallacy"
that is, they inappropriately attempted
to derive "ought to" from "is"
by recommending that pharmaceutical budgets should be based on previously observed prescribing patterns.18 To avoid the fallacy, observed
prescribing patterns must be a suitable basis for determining future
prescribing spends. Prescribing behaviour in one time period may not
reflect changes in pharmaceutical technology and patients' needs in
the next (and may embody an unknown amount of inappropriate and
inefficient prescribing).19 Because a positive approach
was used, practice allocations were based on nationally observed,
historical prescribing patterns rather than on patients' needs locally.
Common deficiencies
As a positive approach was used to construct both the
ASTRO(97)-PU and the needs adjustment formula, both formulas may share
a common set of deficiencies. Firstly, they may be unable to account
for all causes of prescribing cost variation (such as differences in
individual prescribing behaviour and random fluctuations), particularly
as their construction is limited by the availability of high quality
and appropriate data.20 In consequence, legitimate causes
of prescribing cost variations (such as differences in clinical
practice, prescription exemption rates, and the number of nursing home
patients) may not be funded.
21 22
Secondly, as they
recommend only one set of weights for all practices nationally, they
may be of little use to primary care groups, which have to set budgets
that reflect local variations in need.23 Thirdly, as
neither formula is able to measure patients' capacity to benefit from
prescribed drugs, budgets set on this basis may not reflect local
needs. Finally, instead of addressing the problems associated with
budget setting on a historical cost basis, the ASTRO(97)-PU and the
needs adjustment formula may have institutionalised historical
prescribing patterns, with the result that they wrongly attempted to
predict future prescribing patterns on the basis of past
trends.24
Piloting before use
Given the possible limitations of the new needs adjustment
formula for prescribing, the formula should be subjected to piloting in
a small number of practices before it is adopted nationally. Such
piloting should assess the effect of the formula on practitioners'
prescribing behaviour and the volume and types of medicines that
patients receive. Also, the assessment should examine the extent to
which, at a local level, the national weights attached to the variables
included in the formula reflect patients' capacity to benefit from
prescribed drugs. Once these data on the implications of its use have
been collected, the NHS Executive should consider whether the formula is a suitable basis on which to set practice allocations and should issue instructions to primary care groups accordingly. Piloting may
lead to the conclusion that weighted capitation formulas of this type
are an inadequate basis on which to set such budgets and that other
means of allocating prescribing funds need to be found.
| |
Acknowledgments |
|---|
We thank Dr Azeem Majeed and Professor Alain Li Wan Po for comments on an earlier draft of this paper.
Contributors: DLB and DJP were jointly involved in the critical analysis and the writing of this paper. DB is the guarantor.
| |
Footnotes |
|---|
Funding: The authors both work for the Health Economics Facility. No additional funding was secured for this work.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Department of Health. Working for patients. London: HMSO, 1989. |
| 2. | Day P, Klein R. Variations in budgets of fundholding practices. BMJ 1991; 303: 168-170. |
| 3. |
Majeed A.
Allocating budgets for fundholding and prescribing.
BMJ
1996;
313:
1274-1275 |
| 4. |
Majeed A, Head S.
Capitation based prescribing budgets will not work.
BMJ
1998;
316:
748-753 |
| 5. |
Greenhalgh T.
Effective prescribing at practice level should be identified and rewarded.
BMJ
1998;
316:
750-753 |
| 6. | Maxwell M, Howie JGR, Pryde CJ. A comparison of three methods of setting prescribing budgets, using data derived from defined daily dose analyses of historic patterns of use. Br J Gen Pract 1998; 48: 1467-1462[Medline]. |
| 7. |
Smith PC.
Setting budgets for general practice in the new NHS.
BMJ
1999;
318:
776-779 |
| 8. | Department of Health. The new NHS. London: Stationery Office, 1997. (Cm 3807.) |
| 9. | Sleator DJD. Towards accurate prescribing analysis in general practice: accounting for the effects of practice demography. Br J Gen Pract 1993; 43: 102-106[Medline]. |
| 10. | Roberts SJ, Harris CM. Age, sex, and temporary resident originated prescribing units (ASTRO-PUs): new weightings for analysing prescribing of general practices in England. BMJ 1993; 307: 485-488. |
| 11. | Lloyd DCEF, Roberts DJ, Sleator D. Revision of the weights for the age sex temporary resident originated prescribing unit. Br J Med Econ 1997; 11: 81-85. |
| 12. | Culyer AJ. Need and the National Health Service: economics and social choice. London: Martin Robertson, 1976. |
| 13. | Rice N, Dixon P, Lloyd D, Roberts D. Derivation of a needs based capitation formula for allocating prescribing budgets. York: Centre for Health Economics, 1999. (Occasional paper.) |
| 14. |
Majeed FA, Cook DG, Poloniecki J, Griffiths J, Stones C.
Sociodemographic variables for general practices: use of census data.
BMJ
1995;
310:
1373-1374 |
| 15. |
Majeed FA, Cook DG, Poloniecki J, Martin D.
Using data from the 1991 census.
BMJ
1995;
310:
1511-1514 |
| 16. | NHS Executive. Report of the Advisory Committee on Resource Allocation 1998. London: Department of Health, 1999. |
| 17. | Baines DL, Whynes DK. The use of the ASTRO-PU and the ASTRO(97)-PU in the setting of prescribing budgets in English general practice. J Clin Pharm Ther 1998; 23: 229-234[Medline]. |
| 18. | Searle JR. How to derive "ought" from "is." Philosophical Review 1964; 73: 43-58[CrossRef]. |
| 19. | Audit Commission. A prescription for improvement: towards more rational prescribing in general practice. London: HMSO, 1994. |
| 20. | Carr-Hill R, Rice N, Smith PC. Towards locally based resource allocation in the NHS. York: University of York, 1998. (Centre for Health Economics discussion paper.) |
| 21. |
Whynes DK, Baines DL, Tolley KH.
Explaining variations in general practice prescribing costs per ASTRO-PU (age, sex, and temporary resident originated prescribing unit).
BMJ
1996;
312:
488-489 |
| 22. | Lloyd D, Scrivener G. Prescribing for patients in homes: a revised ASTRO-PU. Prescriber 1998; 5(Apr): 33-36. |
| 23. |
Newdick C.
Primary care groups and the right to prescribe.
BMJ
1998;
317:
1361-1365 |
| 24. | Popper K. The poverty of historicism. Reading: Cox and Wyman, 1957. |
(Accepted 22 December 1999)